Eldan, part of the Neopharma group in Israel, Bucher Biotec AG in Switzerland, Imperial Life Sciences in India and several others will accelerate global reach of the Tapestri Platform SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc., the pioneer in single-cell multi-omics and high-throughput DNA analysis today announced that it has entered into distribution agreements with […]
Self-learning microscopy opens new horizons in high-content analysis and advances phenotypic screening Olympus announces the US launch of the scanR high-content screening (HCS) station, a cell imaging solution that utilizes artificial intelligence (AI) to enable next-generation biological research. It combines the modularity and flexibility of a microscope-based setup with the automation, speed, throughput and reproducibility […]
CARLSBAD, Calif. — Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow. To simplify and accelerate the genomic profiling process, Thermo Fisher Scientific announced that the Ion Torrent Oncomine Myeloid Research Assay* will be available in 2020 to run […]
Additional Resources Will Support Continued Commercialization of Akoya’s Spatial Biology Platforms CODEX® and Phenoptics™ Company to present at Piper Jaffray 31st Annual Healthcare Conference Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million financing from both new and existing investors. The round will fund significant growth through expansion of commercial […]
Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally Strategic transaction enables Veracyte to access global markets through a world-class, distributed instrument system, with an initial focus on its pulmonology franchise Provides pathway for long-term revenue growth and margin expansion Veracyte to hold conference call and webcast […]
DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement. MOUNTAIN VIEW, Calif. – DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U.S. Food and Drug Administration (FDA) has awarded DNAnexus a five-year, $20 million contract to power the precisionFDA Collaborative Omics Environment in the […]
Partnership Expands Physician Access to Clinical Testing that May be Performed in Local Laboratories for Solid Tumor Cancers, Hematological Malignancies and Minimal Residual Disease Monitoring BOULDER, Colo.— ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive partnership with Illumina, Inc. (NASDAQ: ILMN) to […]
Creates Potential for Significantly Expanded Test Menu Sharpens NanoString’s Strategic Focus on Rapidly Growing Research Business Including Recent Launch of GeoMx Digital Spatial Profiler Strengthens Financial Profile through Capital Infusion and Streamlined Operations SEATTLE – NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to […]
BEIJING–(BUSINESS WIRE)–Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The approval of a new desktop medium-throughput semiconductor-based next generation sequencing (NGS) system—GENETRON S5, showcases Genetron Health’s ongoing commitment to providing early screening, diagnosis and treatment recommendations, as […]
Cambridge, UK – Abcam’s new engineered knockout cell lysates enable proteomic studies by providing researchers with “true negative” controls. Acquiring reliable off-the-shelf knockout mouse models or cell lines that match specific experimental requirements can be challenging, and often need to be sourced directly from individual researchers or labs. Abcam’s newly-launched collection addresses this issue by […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
